General Information of the Compound
Compound ID
CP0287041
Compound Name
N-(3,4-dihydro-2H-chromen-2-ylmethyl)-N'-pyrimidin-2-ylpropane-1,3-diamine
    Show/Hide
Structure
Formula
C17H22N4O
Molecular Weight
298.39
Canonical SMILES
C(CNCC1CCc2ccccc2O1)CNc1ncccn1
    Show/Hide
InChI
InChI=1S/C17H22N4O/c1-2-6-16-14(5-1)7-8-15(22-16)13-18-9-3-10-19-17-20-11-4-12-21-17/h1-2,4-6,11-12,15,18H,3,7-10,13H2,(H,19,20,21)
    Show/Hide
InChIKey
UBKPEZPIHJFKRG-UHFFFAOYSA-N
Physicochemical Property
logP
2.262
Rotatable Bonds
7
Heavy Atom Count
22
Polar Areas
59.07
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
5
Complexity
22

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 21460905
ChEMBL ID
CHEMBL422243
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000803 HA7 Homo sapiens (Human)  1
1
IC50 = 1.995 nM
   TI
   LI
   LO
   TS